Prawo i regulacje · 20.09.2007

Changes to Patient Limitation for Dispensing or Prescribing Approved Narcotic Controlled Substances for Maintenance or Detoxification Treatment by Qualified Individual Practitioners

The Drug Enforcement Administration (DEA) is proposing to conform its regulations to recent statutory amendments to the Controlled Substances Act that changed certain patient limitations for practitioners who dispense or prescribe certain narcotic drugs for maintenance or detoxification treatment.

Source: Federal Register — Justice DepartmentOpen original release →

Changes to Patient Limitation for Dispensing or Prescribing Approved Narcotic Controlled Substances for Maintenance or Detoxification Treatment by Qualified Individual Practitioners

Notice of Lodging of Proposed Stipulation and Order of Settlement Under the Toxic Substances Control Act

Notice of Lodging of Proposed Final Supplemental Consent Decree Under the Clean Water Act

Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Importer of Controlled Substances Application: Irvine Labs, Inc.

Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection, for Which Approval Has Expired: Title-2026 National Survey of Victim Service Providers

Craig Cohen, DPM; Decision and Order